AUST, Loading Knowledge...

Simultaneous assessment of Atorvastatin-ezetimibe combination in tablets by An Ion-pair RP-HPLC

Doctor Saleh Trefi

 

Abstract:

The purpose of this work was to develop and validate a new ion-pair reversed phase high performance liquid chromatographic method on a standard C18-type stationary phase with UV detection, for the analysis of the two antihyperlipidemic agents as a combination in tablets atorvastatin-ezetimibe
The mobile phase consisted of a 35% of cetyltrimethylammonium bromide (cetrimide) 10-3 M as the ion-pairing agent and 65% acetonitrile. The pH value of the mobile phase was adjusted if necessarily by ammonia solution at 10. The flow rate was 1.5 mL/min and the separation was performed at 40º
The method validation was based on linearity, accuracy, precision and specificity. This method exhibited good linearity and accuracy with mean recovery values between 95-105%, precision with relative standard deviations of the calculated concentrations less than 2% and specificity in the presence of excipients
These results indicates that the proposed method is applicable for the separation and determination of atorvastatin-ezetimibe combination in tablets and could be a relevant method to utilize in quality control laboratories

 

Name of the journal in which the research is published:

Research Journal of Pharmacy and Technology.

 

Publication Date:

2020.

 

Link:

Simultaneous assessment of Atorvastatin-ezetimibe combination in tablets by An Ion-pair RP-HPLC